Open Veils · Answer
Helicobacter pylori and SIBO relationship?
The suppressed clinical picture is that H. pylori infection significantly elevates SIBO risk — roughly 80% higher odds per systematic review data — through mechanisms gastroenterology has been slow to integrate into practice. A dual-pathway hypothesis now formalizes what functional medicine practitioners like Chris Kresser and Nirala Jacobi have long argued clinically: H. pylori is a systemic gut disruptor, not merely a stomach pathogen. Treating one without screening for the other leaves patients in a diagnostic loop. Methane-dominant SIBO (IMO) appears specifically linked to H. pylori colonization, adding another layer mainstream protocols ignore.
Evidence
- According to the dual-pathway framework published in Medical Hypotheses (Aug 2026), H. pylori contributes to SIBO through two distinct but overlapping routes.
- The second pathway operates through corpus-predominant atrophic gastritis: H. pylori destroys parietal cells, acid output drops, and the gastric acid barrier — which normally sterilizes incoming oral and esophageal flora — collapses.
- Researcher Allison Siebecker, who runs the most comprehensive SIBO clinical database in functional medicine, has noted that co-infections are routinely missed because conventional breath testing and H. pylori stool antigen tests are rarely ordered together.
- The methane-SIBO (now classified as intestinal methanogen overgrowth, IMO) link to H. pylori is particularly underreported.
- In virulent-strain, preserved-acid patients, inflammatory signaling impairs enteric neuromuscular function and migrating motor complex (MMC) activity — the intestinal 'housekeeping wave' that sweeps bacteria downward.